Vitreous Detachment Clinical Trial
Official title:
YAG Laser Vitreolysis of Symptomatic Vitreal Floaters
Vitreous fluid, containing 95% water, fills the space behind the lens. Its gelatinous consistency is due to the presence of hyaluronic acid, mucopolysaccharide and collagen fibers. With age, the collagen aggregates into parallel bundles, bound by cross links, leaving the pockets of liquid in the glass body. This redistribution is referred to as syneresis, which is found in 90% older than 40 years. After liquefaction, the vitreous enters the retroviral space and separates the posterior hyaloid membrane from the retina. When separating from the optical disk it forms an annular formation (Weiss ring) in front of the optical disc. These agglomerated collagen bundles (opacities) disperse the photons of light and are perceived by the patients as a "gray silhouette-like artifact". Two major interventions for these symptoms include Nd: YAG laser vitreolysis and vitrectomy. The less invasive method Nd: YAG laser increases the temperature of the opacity thus vaporizing them to smaller fragments that are easier to sediment onto the bottom of the vitreous cavity thereby relieving the symptoms.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 30, 2020 |
Est. primary completion date | October 2, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age 18 years or older - Is able to give written informed consent to the procedure - Patients with clinical symptoms of floaters and clinically confirmed diagnosis of opacity in the vitreous body. Exclusion Criteria: - Inability to tolerate the procedure - Blurred anterior eye segment - Cataract or Intraocular lens opacity - Blurred posterior eye segment - Active eye inflammation - Iris synechiae - Uncontrolled intraocular pressure elevation - Peripheral retinal degeneration |
Country | Name | City | State |
---|---|---|---|
Croatia | University Hospital of Split | Split | Hrvatska |
Lead Sponsor | Collaborator |
---|---|
University Hospital of Split | University of Split, School of Medicine |
Croatia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of patients with resolution of symptoms | Number of patients who reported resolution of symptoms after the treatment | 1 month | |
Secondary | Macular Oedema Development rate | Rate of macular oedema development after the treatment | 1 month | |
Secondary | Rate of treatment side effects | Rate of treatment side effects such as: retinal damage, retinal detachment, cataract... | 1 month | |
Secondary | Retreatment rate | Number of treatment sessions needed for simptom resolution | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04865991 -
Comparison of Propofol Target Controlled Infusion (TCI) and Sevoflurane
|
N/A | |
Not yet recruiting |
NCT04346095 -
Oral Sedation in Vitreoretinal Surgery
|
Phase 4 | |
Completed |
NCT00198471 -
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
|
Phase 2 | |
Completed |
NCT05249413 -
Early Vitrectomy for Endophthalmitis After Cataract Surgery
|
||
Terminated |
NCT02783209 -
Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient
|
N/A |